|
RAD54B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.14440001919291E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.73640000000752E-06 |
| Normal-vs-Stage2 |
3.361900E-03 |
| Normal-vs-Stage3 |
1.750630E-04 |
| Normal-vs-Stage4 |
1.435520E-02 |
| Stage1-vs-Stage2 |
2.920000E-01 |
| Stage1-vs-Stage3 |
3.517800E-02 |
| Stage1-vs-Stage4 |
7.140600E-01 |
| Stage2-vs-Stage3 |
3.235400E-01 |
| Stage2-vs-Stage4 |
7.205200E-01 |
| Stage3-vs-Stage4 |
1.562640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.3490000206935E-09 |
| Normal-vs-AfricanAmerican |
7.79069999999882E-05 |
| Normal-vs-Asian |
2.328500E-02 |
| Caucasian-vs-AfricanAmerican |
1.780180E-01 |
| Caucasian-vs-Asian |
2.023800E-01 |
| AfricanAmerican-vs-Asian |
2.568500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.3146000005525E-08 |
| Normal-vs-Female |
5.54420000020706E-07 |
| Male-vs-Female |
1.447230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.973020E-04 |
| Normal-vs-Extreme_Weight |
6.33820000000007E-05 |
| Normal-vs-Obese |
2.32469999994489E-06 |
| Normal-vs-Extreme_Obese |
2.713800E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.356000E-01 |
| Normal_Weight-vs-Obese |
4.201000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.993200E-01 |
| Extreme_Weight-vs-Obese |
2.639200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.045800E-01 |
| Obese-vs-Extreme_Obese |
6.389700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.804400E-04 |
| Normal-vs-Age(41-60Yrs) |
2.79089995558479E-09 |
| Normal-vs-Age(61-80Yrs) |
3.8066999999975E-06 |
| Normal-vs-Age(81-100Yrs) |
3.632400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.508300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.240420E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.219950E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.992500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.399700E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.716160E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.96159999646895E-08 |
| Normal-VS-Type2 PRCC |
2.570000E-04 |
| Normal-VS-KIRP CIMP |
3.702900E-03 |
| Normal-VS-Unclassified PRCC |
7.57850000000504E-05 |
| Type1 PRCC-VS-Type2 PRCC |
6.410200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.001600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.055800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.971730E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.190600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.106100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.362880E-04 |
| Normal-vs-N1 |
3.201800E-04 |
| Normal-vs-N2 |
3.267600E-01 |
| N0-vs-N1 |
4.748400E-02 |
| N0-vs-N2 |
5.231000E-01 |
| N1-vs-N2 |
7.306000E-01 |
|
|
